CMC Module Development
Authoring and reviewing Module 3 sections with data generated in-house, ensuring alignment with FDA and ICH guidelines.
01
IND/NDA Prep & Review
IND/NDA Preparation with CMC Pharma
Preparing regulatory submissions is one of the most critical milestones in the drug development lifecycle. The IND (Investigational New Drug) application allows your program to enter clinical trials, while the NDA (New Drug Application) secures approval to bring your therapy to market. Each requires comprehensive data packages, consistent documentation, and a clear regulatory strategy to avoid costly delays or deficiencies.
At CMC Pharma, regulatory guidance is fully embedded into the laboratory services we provide, from formulation and analytical method development to stability testing and manufacturing enablement.
This integration ensures that the data we generate is not only scientifically sound, but also submission-ready and aligned with FDA and ICH expectations. By uniting science, operations, and regulatory expertise, we deliver data that is the foundation of your IND and NDA packages, designed to withstand regulatory scrutiny and keep your program on track.
Unlike standalone consultants or routine testing labs, CMC Pharma provides both the data and the regulatory strategy behind it—reducing risk, avoiding costly rework, and accelerating your pathway from preclinical studies to commercialization.
How Our IND/NDA Preparation Services Help You
- Regulatory Compliance Built in: Submissions must meet strict FDA and ICH standards. At CMC, compliance is not an afterthought. Our lab studies are designed from the start with regulatory requirements in mind.
- Program Acceleration: Submissions backed by integrated regulatory insight are more likely to pass review without Refuse-to-File (RTF) decisions or Complete Response Letters (CRLs).
- Cost Efficiency: Our end-to-end model avoids the need for multiple consultants or separate vendors. The same experts who generate your data also ensure it is fit-for-submission.
The CMC Pharma Advantage: Integrated, End-to-End Support
At CMC Pharma, we are not just consultants, and we offer development services beyond those of a testing lab. We are a full-service development partner with the expertise to:
- Deliver regulatory-ready data from our own laboratories.
- Integrate formulation, analytical, stability, and manufacturing oversight with regulatory strategy.
- Act as an extension of your team to reduce hiring needs, control costs, and provide continuity across the lifecycle.
- Anticipate regulatory questions and proactively build submissions that withstand scrutiny.
- No hand-offs between labs and consultants.
- Fewer delays caused by misaligned data or incomplete documentation.
- Smarter resource use, eliminating the need for additional hires or external vendors.
We act as a true extension of your team, providing not only the technical execution but also the regulatory foresight to ensure IND and NDA success.
Accelerating Regulatory Success
CMC Pharma helps clients de-risk regulatory submissions while accelerating the path from discovery to market. By embedding regulatory guidance into every stage of development, we ensure your product is ready for review without unnecessary delays, costly rework, or fragmented data.
- With CMC as your regulatory partner, you gain:
- Predictable timelines through proactive planning and gap closure.
- Cost savings by eliminating the need for multiple external consultants.
- Regulatory confidence knowing your submission has been reviewed by experts who understand both science and strategy.
explore our Integrated Regulatory Support Services
Send a message
Partner with CMC Pharma
Successful IND, NDA, and other regulatory submissions require more than checklists. They demand integrated expertise across science, operations, and compliance. With CMC Pharma, you gain a partner committed to accelerating your program, reducing risk, and ensuring regulatory success.